Wedbush Reiterates Outperform Rating for Alight (NYSE:ALIT)
Wedbush reaffirmed their outperform rating on shares of Alight (NYSE:ALIT – Free Report) in a report released on ...
Wedbush Reiterates “Outperform” Rating for Scholar Rock (NASDAQ:SRRK)
Wedbush reiterated their outperform rating on shares of Scholar Rock (NASDAQ:SRRK – Free Report) in a report issued on ...
International Business Machines Corporation (IBM) Joins Wedbush’s Best Ideas List as AI Demand Surges Across Enterprises
We recently published a list of 9 Trending AI Stocks Making Headlines Today. In this article, we are going to take a look at ...
Wedbush Analysts Say Musk Needs to Announce He Will 'Balance DOGE and Being Tesla CEO'
KEY TAKEAWAYS Long-time Tesla bull Dan Ives, an analyst at Wedbush Securities, says Elon Musk is the only one who can turn ...
IBM’s Strategic Advantage: A Highlight from Wedbush's Best Ideas List
For example, Ives notes that IBM’s recent growth in cloud penetration allows the company to monetize its vast installed base effectively over the next 12 to 18 months. This insight is particularly ...
Wedbush Sees AI Stocks Surging in Late 2025-Here's Why the Sell-Off May Be Temporary
Market fears over tariffs and growth have hit tech stocks, but Wedbush sees the dip as a buying opportunity for long-term investors ...
Wedbush ups National CineMedia to Outperform on valuation as backdrop improves
As previously reported, Wedbush upgraded National CineMedia (NCMI) to Outperform from Neutral with a $7.50 price target The firm believes the ...
Zenas BioPharma initiated with an Outperform at Wedbush
Wedbush initiated coverage of Zenas BioPharma (ZBIO) with an Outperform rating and $35 price target Light Up your Portfolio with Spark:Easily ...